Kalnem-250

Kalnem-250

MRP: ₹690/-

Therapy of moderate and severe bacterial infections. Active against gram positive and gram negative bacteria. Applied to skin, soft tissue, urinary tract, intra-abdominal and respiratory tract infections. Assists in the treatment of other antibiotic resistant hospital acquired infections.

0

Years Of Experience

PCD Pharma Franchise

We help pharma professionals to establish successful businesses with a wide product portfolio.

Partner With Us

Apply for PCD Pharma Franchise in your region.

✔ WHO-GMP Certified ✔ Monopoly Rights ✔ High Margins

Start Your Own PCD Pharma Franchise with Monopoly Rights.

Your information is 100% secure & confidential.

Pharmacovigilance & ADR Reporting

  • Committed to patient safety and responsible pharmacovigilance.
  • Report any suspected Adverse Drug Reaction (ADR) promptly.
  • Supporting safe and compliant use of medicines.
Scroll to Top

Download Products List

Enter details for instant PDF access

Partner With Us

Apply for PCD Pharma Franchise in your region.

✔ WHO-GMP Certified ✔ Monopoly Rights ✔ High Margins

Start Your Own PCD Pharma Franchise with Monopoly Rights.

Your information is 100% secure & confidential.